血清proGRP联合NLR对淋巴结转移因素分析及甲状腺癌的诊断

摘要/Abstract

摘要： 目的分析血清胃泌素释放肽前体（proGRP）联合中性粒细胞/淋巴细胞比值（NLR）对淋巴结转移的关系及甲状腺癌的诊断。方法选择2020年1月—2023年1月西安航天总医院收治的140例甲状腺结节患者作为研究对象,以病理结果为金标准,将其中70例甲状腺癌患者作为观察组,另70例甲状腺良性结节患者为对照组,同时根据观察组患者淋巴结是否转移划分为转移组（33例）和未转移组（37例）。分别比较观察组与对照组、转移组与非转移组血清proGRP及NLR指标值差异,测算血清proGRP及NLR对甲状腺癌及淋巴结转移的诊断效能。结果观察组患者proGRP及NLR指标值高于对照组,差异具有统计学意义（P<0.05）,转移组患者血清proGRP及NLR指标值高于非转移组,差异具有统计学意义（P<0.05）;血清proGRP联合NLR指标诊断甲状腺癌的灵敏度、特异度、准确度、阳性预测值及阴性预测值均高于各指标单独检测,差异具有统计学意义（P<0.05）;血清proGRP联合NLR指标预测甲状腺癌伴淋巴结转移的灵敏度、特异度、准确度、阳性预测值及阴性预测值均高于各指标单独预测,差异具有统计学意义（P<0.05）。结论血清proGRP联合NLR对甲状腺癌具有较高的诊断价值,同时二者与甲状腺癌伴淋巴结转移关系密切,提前做好指标检测对淋巴结转移风险具有一定的预测价值。

关键词: 血清胃泌素释放肽前体, 中性粒细胞/淋巴细胞比值, 甲状腺癌, 淋巴结转移

Abstract: Objective The relationship of serum gastrin-releasing peptide precursor (proGRP) combined with neutrophil/lymphocyte ratio (NLR) on lymph node metastasis and the diagnosis of thyroid cancer were analyzed. Methods The 140 patients with thyroid nodules admitted to Xi'an Aerospace General Hospital between January 2020 and January 2023 were selected as the study object, with pathological results as the gold standard, 70 patients with thyroid cancer were taken as the observation group, the other 70 patients with benign thyroid nodules as the control group, and the patients were divided into metastasis group (n=33) and non metastasis group (n=37). The diagnostic efficacy of serum proGRP and NLR in thyroid cancer and lymph node metastasis was calculated by comparing the difference of serum proGRP and NLR index values respectively. Results The proGRP and NLR values of patients in observation group were higher than those of control group, the difference was statistically significant(P<0.05), and the serum proGRP and NLR values of patients in metastasis group were higher than those of non-metastasis group, and the difference was statistically significant(P<0.05); the sensitivity, specificity, accuracy, positive predictive value and negative predictive value of serum proGRP and NLR index were respectively higher than that of each index alone, and the difference was statistically significant(P<0.05); the sensitivity, specificity, accuracy, positive predictive value and negative predictive value of serum proGRP combined with NLR index to predict thyroid cancer with lymph node metastasis were higher than that of each index alone, and the difference was statistically significant(P<0.05). Conclusion Serum proGRP combined with NLR has high diagnostic value for thyroid cancer, and the two are closely related to thyroid cancer with lymph node metastasis, so the index detection in advance has certain predictive value for the risk of lymph node metastasis.

Key words: Serum gastrin releasing peptide precursor, Neutrophil/lymphocyte ratio, Thyroid cancer, Lymph node metastasis

中图分类号:

R736.1

许武山, 魏晓娟. 血清proGRP联合NLR对淋巴结转移因素分析及甲状腺癌的诊断[J]. 中华养生保健, 2023, 41(20): 57-60.

XU Wu-shan WEI Xiao-juan. Analysis of Serum proGRP Combined with NLR for Lymph Node Metastasis Factors and the Diagnosis of Thyroid Cancer[J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(20): 57-60.

参考文献

[1] OFFI C, ROMANO R M, CANGIANO A, et al.Evaluation of LMR, NLR and PLR as predictors of malignancy in indeterminate thyroid nodules[J]. Acta Otorhinolaryngol Ital,2021,41(6):530-536.
[2] 徐如意,唐红,白浪.新发或未控制甲状腺功能亢进症导致肝损伤的诊断与治疗[J].中华肝脏病杂志,2021,29(10):926-931.
[3] 王晔龙,于海文.血清β-Klotho、FGF-19和FGFR-4检测对分化型甲状腺癌的诊断价值[J].检验医学与临床,2023,20(3):374-378.
[4] 苏毅,李影.某院甲状腺癌发病规律及临床特点分析[J].中国病案,2020,21(3):63-65.
[5] GIOVANELLA L, FONTANA M, KELLER F, et al.Circulating pro-gastrin releasing peptide (ProGRP) in patients with medullary thyroid carcinoma[J]. Clin Chem Lab Med, 2021,59(9):1569-1573.
[6] 张波,徐景竹,吴琼.2015年美国甲状腺学会《成人甲状腺结节与分化型甲状腺癌诊治指南》解读:超声部分[J].中国癌症杂志,2016,26(1):19-24.
[7] 张灵羽,付利军,孙宁,等.血清proGRP、Ctn、CEA在甲状腺髓样癌鉴别诊断和预测颈侧区淋巴结转移中的价值[J].郑州大学学报(医学版),2022,57(2):271-275.
[8] 许克,杨枋,谢应海,等.NLR、TgAb与甲状腺乳头状癌颈部淋巴结转移的关系[J].中国医药导报,2020,17(11):93-97.
[9] 洪文斌,胡竑韡.NLR、PLR在甲状腺良恶性结节及自身免疫性甲状腺炎诊断中的应用价值[J].分子诊断与治疗杂志,2020,12(5):643-646+655.
[10] 马文飚,石博,夏蕾,等.lncRNA SNHG14通过靶向miR-433-3p调控甲状腺癌SW579细胞的恶性生物学行为[J].中国肿瘤生物治疗杂志,2022,29(6):534-540.
[11] 韦琦丽,田丽玲,农秀明.甲状腺癌超声诊断技术应用进展[J].中国肿瘤临床与康复,2020,27(8):1019-1021.
[12] 余慧,侯庆兵.彩色多普勒超声、MRI和血清促甲状腺激素水平联合诊断分化型甲状腺癌的价值[J].广西医学,2021,43(2):186-188.
[13] 吕新华,杨付红,常亚歌.超声剪切波弹性成像对甲状腺癌包膜侵犯、淋巴结转移的诊断价值及其与促甲状腺素水平的相关性[J].实用癌症杂志,2023,38(2):316-319.
[14] 吕明闯,王红岩.血清神经元特异性烯醇化酶、胃泌素释放肽前体在小细胞肺癌中的表达意义[J].河南医学研究,2022,31(7):1219-1222.
[15] 王刚,谢丽娟,张明菊.超声引导下颈淋巴结穿刺联合血清TSH、SIL-2R水平检测与甲状腺癌患者颈部淋巴结转移及疾病严重程度的关系[J].河北医科大学学报,2020,41(4):436-439.
[16] 彭雄文,沈乐园,宋仕聪.血清肿瘤标志物胃泌素释放肽前体和神经特异性烯醇化酶在小细胞肺癌辅助诊断及疗效评价中的意义[J].解放军医药杂志,2018,30(5):15-18.
[17] LI S, LIU Y, LIU S, et al.Predictive Values of Inflammation-Related Markers and Thyroid Function in Pediatric Thyroid Cancer Patients[J]. Frontiers in Pediatrics, 2021,51:1510-1510.
[18] 何家明,胡金连.术前SII、NLR、PLR在分化型甲状腺癌中的诊断价值分析[J].中国医学文摘(耳鼻咽喉科学),2021,36(4):98-99.
[19] 曹锐,文艺,漆芹伶,等.NLR、PLR在分化型甲状腺癌患者诊治中的研究进展[J].四川医学,2022,43(10):1028-1032.
[20] 李灿晓,梁楠,李世杰,等.淋巴细胞相关炎症指数预测甲状腺癌预后研究进展[J].中国实用外科杂志,2021,41(6):706-709.
[21] 杨尊敬,杜先玲.细胞周期蛋白依赖性激酶在miR-193a5p调控卵巢癌细胞增殖及上皮细胞间充质转变中的作用[J].中国应用生理学杂志,2020(2):176-180.